The National Committee for Quality Assurance (NCQA) has released its highly anticipated 2026 health plan ratings, offering a diagnostic snapshot of the U.S. insurance landscape. The findings paint a picture of an industry in the midst of a significant, performance-driven evolution. As insurers face mounting pressure from regulators and a cynical public, the latest data shows a definitive trend: quality is rising, driven by targeted investments in behavioral health and chronic disease management.
The NCQA—a private, nonprofit organization—serves as the arbiter of performance for the healthcare industry. Its annual report cards, which mirror the federal 0-to-5 star system used for Medicare Advantage plans, have become the gold standard for consumers and policymakers evaluating the efficacy of private insurance.
In the 2026 report, the industry achieved a notable milestone: 18 health plans earned the coveted 5-star designation. This represents a significant acceleration from previous years, where 11 plans achieved the top tier in 2025, which was itself more than double the count from 2024. Despite a slight dip in the number of plans achieving 4-star and 4.5-star ratings, the overarching trend is one of convergence, as the performance gap between the industry’s high and low achievers continues to narrow.
The Chronology of Quality Improvement
The upward trajectory in health plan ratings is not a sudden phenomenon but rather the result of a multi-year shift in strategic priorities. Over the last three years, the insurance sector has moved away from purely cost-containment models toward a more holistic focus on member experience.
- 2024: The industry began to see the fruits of post-pandemic investments in digital health tools and improved patient communication.
- 2025: A breakout year for high-performing plans, with 11 organizations securing 5-star ratings. This signaled that the "continuity of care" initiatives—emphasizing regular check-ins and integrated care models—were successfully yielding measurable outcomes.
- 2026: The current cycle confirms the trend, with 18 plans hitting the 5-star mark. This year’s data also highlights a maturation in how insurers handle complex health issues, particularly in mental health, which had historically been a weak point in plan performance metrics.
Supporting Data: Where the Gains Are Concentrated
The NCQA’s report is not merely a list of winners and losers; it is a granular map of where the industry is successfully moving the needle. The most significant gains have been identified in two key sectors: behavioral health and chronic disease management.
According to the report, "follow-up after hospitalization for mental illness" saw one of the most substantial year-over-year improvements. This is a critical metric, as timely follow-up is statistically tied to lower readmission rates and better long-term health outcomes. Furthermore, nearly four-fifths of all chronic disease management measures—ranging from diabetes blood sugar control to hypertension management—showed measurable improvement across the board.
The data suggests that the "variation" that once plagued the industry is shrinking. Historically, a patient’s health outcomes were heavily dependent on the specific insurer’s internal processes, leading to massive discrepancies in care quality. Now, as standardized performance measures become the norm, even mid-tier plans are finding themselves incentivized to adopt the best practices of the top-tier 5-star plans.
The Structural Divide: Nonprofit vs. For-Profit Performance
Perhaps the most contentious finding in the 2026 report is the continued, well-documented performance gap between nonprofit and for-profit health insurers. Despite the industry’s general improvement, nonprofit plans consistently outperform their for-profit counterparts.
Researchers point to fundamental structural incentives to explain this discrepancy. For-profit insurers, which are often beholden to Wall Street analysts and shareholders, must balance the delivery of quality care with the mandate to generate quarterly profits. This frequently leads to a tighter control on administrative and medical costs, which some studies suggest can inadvertently dampen quality improvement initiatives.
In contrast, nonprofit insurers—which do not have shareholders—are theoretically permitted to reinvest all excess income directly back into their operations. This allows for greater allocation of capital toward patient care, care coordination, and quality improvement infrastructure.
The 2026 ratings underscore this divide:
- Kaiser Permanente’s Dominance: Nine of the 18 plans that achieved a 5-star rating are operated by Kaiser Permanente. For the 11th consecutive ratings cycle, Kaiser has maintained more 5-star and 4.5-star plans combined than any other healthcare organization in the nation.
- The For-Profit Landscape: Among the major publicly traded insurers, performance remained varied. While Aetna demonstrated stronger results relative to its publicly traded peers, other giants, such as Cigna, trailed the pack in overall star ratings. On average, the large for-profit firms hovered between the 3- and 4-star range.
Official Responses and Industry Perspectives
Dr. Vivek Garg, president and CEO of the NCQA, emphasized the positive implications of these findings during the release of the ratings.
"The progress reflected in this year’s Health Plan Ratings is encouraging because it demonstrates meaningful improvement in the areas that matter most to patients, such as behavioral health and chronic disease management," Dr. Garg stated. By highlighting these specific areas, the NCQA is effectively setting a new bar for what constitutes a "high-performing" plan, pushing the industry to focus on outcomes rather than just network size or premiums.
However, the industry’s internal PR efforts—often focused on touting these high ratings—are colliding with a harsher reality outside of the boardroom. Insurers are currently engaged in a massive branding push to repair their image. As Americans grapple with persistent inflation and rising healthcare costs, public sentiment toward the insurance industry has reached a low ebb.
Implications: The Consumer Trust Gap
The disconnect between the NCQA’s rising star ratings and the public’s plummeting satisfaction levels is a critical issue for the future of the American healthcare system.
According to recent data from J.D. Power, consumer satisfaction with health plans is slipping. The primary driver of this dissatisfaction is the widespread belief that insurers are prioritizing corporate profits over patient care. Even as insurers improve their clinical metrics—achieving higher star ratings through better chronic disease management and mental health support—that success is being overshadowed by public frustration over high out-of-pocket costs and restrictive coverage denials.
Looking Ahead: The Future of Health Plan Accountability
The 2026 NCQA ratings suggest that the insurance industry is becoming more technically proficient at delivering care. The widespread improvement in chronic disease metrics is a genuine win for public health. However, the report also serves as a warning: technical quality is only one side of the coin.
For insurers, the next challenge will be bridging the gap between "quality scores" and "consumer trust." Achieving a 5-star rating is an objective marker of success, but it may prove insufficient if the average patient continues to perceive their insurer as an adversary in their financial life.
As the industry moves into the next cycle, policymakers will likely use these NCQA ratings to push for further transparency, particularly among for-profit entities. The pressure to justify high premiums with high-quality outcomes will only increase. Whether the industry can leverage these improvements in care quality to win back the American consumer remains the most significant, and as of yet unanswered, question of the 2026 reporting year.
